Basic Information
| RNALocate ID: | RLID:11002422 |
| RNA Symbol: | hsa-miR-361-5p |
| Localization: | Extracellular vesicle |
RNA Information
| RNA Name: | hsa-miR-361 |
| RNA ID: | miRBase:MIMAT0000703 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22849433 |
| Tissue/Cell Line: | HEK-293T cells |
| Method: | Next-generation RNA sequencing |
| Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002009 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002010 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01002011 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002012 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002013 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002014 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002414 | Exosome | Serum | 18589210 |
| RLID:11002415 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11002416 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002417 | Exosome | Renal cancer cells | 21670082 |
| RLID:11002418 | Exosome | Brain tissue | 23382797 |
| RLID:11002419 | Exosome | Plasma | 23663360 |
| RLID:11002420 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002421 | Exosome | Serum | 25349172 |
| RLID:11002423 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000117 | Exosome | Blood|Kidney tissue | |
| RLID-D:11000406 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-361-5p | Oral squamous cell carcinoma | MNDR-E-MI-43463 |
| MNDR | hsa-miR-361-5p | Medulloblastoma | MNDR-E-MI-43464 |
| MNDR | hsa-miR-361-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-43465 |
| MNDR | hsa-miR-361-5p | Lymphoma | MNDR-E-MI-43466 |
| MNDR | hsa-miR-361-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-43467 |
| MNDR | hsa-miR-361-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-43468 |
| MNDR | hsa-miR-361-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-43469 |
| MNDR | hsa-miR-361-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-43470 |
| MNDR | hsa-miR-361-5p | Her2-receptor positive breast cancer | MNDR-E-MI-43471 |
| MNDR | hsa-miR-361-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-43472 |
| MNDR | hsa-miR-361-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-43473 |
| MNDR | hsa-miR-361-5p | Dermatomyositis | MNDR-E-MI-43474 |
| MNDR | hsa-miR-361-5p | Prostate cancer | MNDR-E-MI-43475 |
| MNDR | hsa-miR-361-5p | Gastric cancer | MNDR-E-MI-43476 |
| MNDR | hsa-miR-361-5p | Alzheimer disease | MNDR-E-MI-43477 |
| MNDR | hsa-miR-361-5p | Intracranial aneurysm | MNDR-E-MI-43478 |
| MNDR | hsa-miR-361-5p | Dysautonomia familial | MNDR-E-MI-43479 |
| MNDR | hsa-miR-361-5p | Muscular dystrophy duchenne | MNDR-E-MI-43480 |
| MNDR | hsa-miR-361-5p | Primary biliary cirrhosis | MNDR-E-MI-43481 |
| MNDR | hsa-miR-361-5p | Graves disease | MNDR-E-MI-43482 |
| MNDR | hsa-miR-361-5p | Leukemia | MNDR-E-MI-43483 |
| MNDR | hsa-miR-361-5p | Cardiovascular disease | MNDR-E-MI-43484 |
| MNDR | hsa-miR-361-5p | Carotid stenosis | MNDR-E-MI-43485 |
| MNDR | hsa-miR-361-5p | Moyamoya disease | MNDR-E-MI-43486 |
| MNDR | hsa-miR-361-5p | Lung cancer | MNDR-E-MI-43487 |
| MNDR | hsa-miR-361-5p | Parkinson disease | MNDR-E-MI-43488 |
| MNDR | hsa-miR-361-5p | Breast cancer | MNDR-E-MI-43489 |
| MNDR | hsa-miR-361-5p | Pituitary neoplasms | MNDR-E-MI-43490 |
| MNDR | hsa-miR-361-5p | Pancreatic cancer | MNDR-E-MI-43491 |
| MNDR | hsa-miR-361-5p | Melanoma | MNDR-E-MI-43492 |
| MNDR | hsa-miR-361-5p | Nephroblastoma | MNDR-E-MI-43493 |
| MNDR | hsa-miR-361-5p | Colon cancer | MNDR-E-MI-43494 |
| MNDR | hsa-miR-361-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-43495 |
| MNDR | hsa-miR-361-5p | Ovarian cancer | MNDR-E-MI-43496 |
| MNDR | hsa-miR-361-5p | Prostate adenocarcinoma | MNDR-E-MI-43497 |
| MNDR | hsa-miR-361-5p | Carcinoma ductal breast | MNDR-E-MI-43498 |
| MNDR | hsa-miR-361-5p | Glioblastoma | MNDR-E-MI-43499 |
| MNDR | hsa-miR-361-5p | Glioma | MNDR-E-MI-43500 |
| MNDR | hsa-miR-361-5p | Central nervous system lymphoma | MNDR-E-MI-43501 |
| MNDR | hsa-miR-361-5p | Chordoma | MNDR-E-MI-43502 |
| MNDR | hsa-miR-361-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-43503 |
| MNDR | hsa-miR-361-5p | Epilepsy temporal lobe | MNDR-E-MI-43504 |
| MNDR | hsa-miR-361-5p | Osteosarcoma | MNDR-E-MI-43505 |
| MNDR | hsa-miR-361-5p | Inclusion body myositis | MNDR-E-MI-43506 |
| MNDR | hsa-miR-361-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-43507 |
| MNDR | hsa-miR-361-5p | Gastric adenocarcinoma | MNDR-E-MI-43508 |
| MNDR | hsa-miR-361-5p | Cervical squamous cell carcinoma | MNDR-E-MI-43509 |
| MNDR | hsa-miR-361-5p | Pituitary adenoma | MNDR-E-MI-43510 |
| MNDR | hsa-miR-361-5p | Lung squamous cell carcinoma | MNDR-E-MI-43511 |
| MNDR | hsa-miR-361-5p | Non-small cell lung cancer | MNDR-E-MI-43512 |
| MNDR | hsa-miR-361-5p | Lung adenocarcinoma | MNDR-E-MI-43513 |
| MNDR | hsa-miR-361-5p | Adrenocortical cancer | MNDR-E-MI-43514 |
| MNDR | hsa-miR-361-5p | Thyroid carcinoma | MNDR-E-MI-43515 |
| MNDR | hsa-miR-361-5p | Papillary thyroid carcinoma | MNDR-E-MI-43516 |
| MNDR | hsa-miR-361-5p | Bladder urothelial carcinoma | MNDR-E-MI-43517 |
| MNDR | hsa-miR-361-5p | Pancreatic adenocarcinoma | MNDR-E-MI-43518 |
| MNDR | hsa-miR-361-5p | Carcinoma renal cell | MNDR-E-MI-43519 |
| MNDR | hsa-miR-361-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-43520 |
| MNDR | hsa-miR-361-5p | Clear cell renal cell carcinoma | MNDR-E-MI-43521 |
| MNDR | hsa-miR-361-5p | Cholangiocarcinoma | MNDR-E-MI-43522 |
| MNDR | hsa-miR-361-5p | Pancreatitis | MNDR-E-MI-43523 |
| MNDR | hsa-miR-361-5p | Esophageal cancer | MNDR-E-MI-43524 |
| MNDR | hsa-miR-361-5p | Lung small cell carcinoma | MNDR-E-MI-43525 |
| MNDR | hsa-miR-361-5p | Encephalopathy bovine spongiform | MNDR-E-MI-43526 |
| MNDR | hsa-miR-361-5p | Synovial sarcoma | MNDR-E-MI-43527 |
| MNDR | hsa-miR-361-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-43528 |
| MNDR | hsa-miR-361-5p | Adenoma | MNDR-E-MI-43529 |
| MNDR | hsa-miR-361-5p | Breast invasive carcinoma | MNDR-E-MI-43530 |
| MNDR | hsa-miR-361-5p | Hepatocellular carcinoma | MNDR-E-MI-43531 |
| MNDR | hsa-miR-361-5p | B-cell lymphoma | MNDR-E-MI-43532 |
| MNDR | hsa-miR-361-5p | Rheumatoid arthritis | MNDR-E-MI-43533 |
| MNDR | hsa-miR-361-5p | Hodgkin lymphoma | MNDR-E-MI-43534 |
| MNDR | hsa-miR-361-5p | Burkitt lymphoma | MNDR-E-MI-43535 |
| MNDR | hsa-miR-361-5p | Neuromyelitis optica | MNDR-E-MI-43536 |
| MNDR | hsa-miR-361-5p | Colorectal cancer | MNDR-E-MI-43537 |
| MNDR | hsa-miR-361-5p | Nasopharynx carcinoma | MNDR-E-MI-43538 |
| MNDR | hsa-miR-361-5p | Nasopharyngeal cancer | MNDR-E-MI-43539 |
| MNDR | hsa-miR-361-5p | Stroke lacunar | MNDR-E-MI-43540 |
| MNDR | hsa-miR-361-5p | Breast cancer her3+ negative | MNDR-E-MI-43541 |
| MNDR | hsa-miR-361-5p | Cutaneous squamous cell carcinoma | MNDR-E-MI-43542 |
| MNDR | hsa-miR-361-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-43543 |
| MNDR | hsa-miR-361-5p | Tubulovillous adenoma | MNDR-E-MI-43544 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022785 |
TOP